Merck (MRK) volatility flat into upgrade to Buy at Citigroup
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $128.24 -0.88%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.9%
Revenue Growth %: +3.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.9%
Revenue Growth %: +3.5%
Join SI Premium – FREE
Merck (NYSE: MRK) overall option implied volatility of 17 is near its 26-week average according to Track Data, suggesting non-directional price movement into an upgraded to Buy from Neutral at Citigroup.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) PT Raised to $155 at Scotiabank
- AMD (AMD) call put ratio 1.7 calls to 1 put as share price up 3.2%
- U.S. House committee opens investigation into Merck, AbbVie China drug trials - Reuters
Create E-mail Alert Related Categories
OptionsRelated Entities
Citi, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
